Actively Recruiting
AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention
Led by Brigham and Women's Hospital · Updated on 2026-01-23
1500
Participants Needed
1
Research Sites
174 weeks
Total Duration
On this page
Sponsors
B
Brigham and Women's Hospital
Lead Sponsor
N
Nano-X Imaging Limited
Collaborating Sponsor
AI-Summary
What this Trial Is About
AI INFORM is a multicenter randomized trial that will test the hypothesis that providing clinicians information on the presence and amount of coronary artery calcifications (CAC), will result in initiation or intensification of preventive therapies. The study will use a cloud-based artificial intelligence (AI) platform (Nanox.AI) that can analyze non contrast chest CT and estimate the amount of CAC.
CONDITIONS
Official Title
AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged between 40-75 with prior chest CT within last 3 years
You will not qualify if you...
- Prior coronary artery disease
- Prior cancer
- Other life-limiting condition
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02445
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here